TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.
Abelman RO, Wu B, Barnes H, Medford A, Norden B, Putur A, Bitman E, Thant W, Liu T, Weipert C, Fell G, Spring LM, Wander S, Moy B, Vidula N, Isakoff SJ, Varkaris A, Juric D, Corcoran R, Ellisen LW, Bardia A.
Abelman RO, et al. Among authors: liu t.
Clin Cancer Res. 2025 Jan 2. doi: 10.1158/1078-0432.CCR-24-2771. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 39745368